132 related articles for article (PubMed ID: 3061696)
41. The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.
Inoue M; Yagishita S; Ryo M; Hasegawa K; Amano N; Matsushita M
Acta Neuropathol; 1997 Jun; 93(6):585-91. PubMed ID: 9194897
[TBL] [Abstract][Full Text] [Related]
42. Bromocriptine therapy in striatonigral degeneration.
Van Leeuwen RB; Perquin WV
J Neurol Neurosurg Psychiatry; 1988 Apr; 51(4):592. PubMed ID: 3379440
[No Abstract] [Full Text] [Related]
43. Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes: a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration.
Malessa S; Hirsch EC; Cervera P; Duyckaerts C; Agid Y
Neurology; 1990 Nov; 40(11):1739-43. PubMed ID: 1978260
[TBL] [Abstract][Full Text] [Related]
44. Striatonigral degeneration disputed in familial disorder.
Nielsen SL
Neurology; 1977 Mar; 27(3):306. PubMed ID: 557771
[No Abstract] [Full Text] [Related]
45. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
Decressac M; Mattsson B; Björklund A
Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
[TBL] [Abstract][Full Text] [Related]
46. Neuropathology of the substantia nigra.
Gibb WR
Eur Neurol; 1991; 31 Suppl 1():48-59. PubMed ID: 1830274
[TBL] [Abstract][Full Text] [Related]
47. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
48. [A case at Salpêtrière hospital November 1990. Parkinson syndrome with poor response to dopa therapy in a 64 year-old man].
Dubas F; Vidailhet M; Henin D
Rev Neurol (Paris); 1992; 148(8-9):580-5. PubMed ID: 1494735
[No Abstract] [Full Text] [Related]
49. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
Waldner R; Puschban Z; Scherfler C; Seppi K; Jellinger K; Poewe W; Wenning GK
Neuroscience; 2001; 102(3):581-92. PubMed ID: 11226695
[TBL] [Abstract][Full Text] [Related]
50. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
[TBL] [Abstract][Full Text] [Related]
51. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.
Pillon B; Gouider-Khouja N; Deweer B; Vidailhet M; Malapani C; Dubois B; Agid Y
J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):174-9. PubMed ID: 7876847
[TBL] [Abstract][Full Text] [Related]
52. [Symptomatic laterality and magnetic resonance imaging (MRI) of the putamen in striatonigral degeneration (SND)].
Yanagihara C; Ichikawa K; Kageyama Y; Satou M; Hoshino M
Rinsho Shinkeigaku; 1994 Apr; 34(4):326-30. PubMed ID: 8026124
[TBL] [Abstract][Full Text] [Related]
53. Striatonigral degeneration combined with olivopontocerebellar atrophy with subcortical dementia and hallucinatory state.
Fukutani Y; Takeuchi N; Kobayashi K; Miyazu K; Yamaguchi N; Terada T; Nakamura I; Isaki K
Dementia; 1995; 6(4):235-40. PubMed ID: 7550604
[TBL] [Abstract][Full Text] [Related]
54. Vascular parkinsonism in a CADASIL case with an intact nigrostriatal dopaminergic system.
Wegner F; Strecker K; Schwarz J; Wagner A; Heinritz W; Sommerer F; Thal DR; Schneider JP; Kendziorra K; Sabri O
J Neurol; 2007 Dec; 254(12):1743-5. PubMed ID: 18004646
[No Abstract] [Full Text] [Related]
55. [Clinical and MRI correlation in multiple system atrophy].
Negoro K; Morimatsu M
No To Shinkei; 1994 May; 46(5):473-8. PubMed ID: 8060686
[TBL] [Abstract][Full Text] [Related]
56. Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease.
Oiwa Y; Sanchez-Pernaute R; Harvey-White J; Bankiewicz KS
J Neurosurg; 2003 Jan; 98(1):136-44. PubMed ID: 12546362
[TBL] [Abstract][Full Text] [Related]
57. Infantile bilateral striatal necrosis. Clinical and morphological report of a case and a review of the literature.
Röyttä M; Olsson I; Sourander P; Svendsen P
Acta Neuropathol; 1981; 55(2):97-103. PubMed ID: 6118994
[TBL] [Abstract][Full Text] [Related]
58. Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
Bezard E; Jaber M; Gonon F; Boireau A; Bloch B; Gross CE
Eur J Neurosci; 2000 Aug; 12(8):2892-900. PubMed ID: 10971632
[TBL] [Abstract][Full Text] [Related]
59. Neuropathology of Parkinson's disease and related syndromes.
Gibb WR
Neurol Clin; 1992 May; 10(2):361-76. PubMed ID: 1584179
[TBL] [Abstract][Full Text] [Related]
60. Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy.
Schwarz J; Weis S; Kraft E; Tatsch K; Bandmann O; Mehraein P; Vogl T; Oertel WH
J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):98-101. PubMed ID: 8558163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
